Clinical trial
Adjunctive Glycine for Obsessive Compulsive Disorder
NCT00405535 is registered in ClinicalTrials.gov with Nathan Kline Institute for Psychiatric Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjunctive Glycine for Obsessive Compulsive Disorder
- Lead sponsor
- Nathan Kline Institute for Psychiatric Research
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2004
- Completion date
- December 31, 2006
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obsessive compulsive disorder